Fetal brady- and tachyarrhythmias: New and accepted diagnostic and treatment methods

Southall, 1980, Prospective study of fetal heart rate and rhythm patterns, Arch Dis Child, 55, 506, 10.1136/adc.55.7.506 Jaeggi, 1998, Ventriculo-atrial time interval measured on M-mode echocardiography: a determining element in the diagnosis, treatment and prognosis of fetal supraventricular tachycardia, Heart, 79, 582, 10.1136/hrt.79.6.582 Fouron, 2000, Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions, Obstet Gynecol, 96, 732, 10.1016/S0029-7844(00)01007-3 Rein, 2002, Use of tissue velocity imaging in the diagnosis of fetal cardiac arrhythmias, Circulation, 106, 1827, 10.1161/01.CIR.0000031571.92807.CC Fouron, 2003, Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings, Heart, 89, 1211, 10.1136/heart.89.10.1211 Jaeggi, 2004, Is immune-mediated complete fetal atrioventricular block reversible by transplacental dexamethasone therapy?, Ultrasound Obstet Gynecol, 23, 602, 10.1002/uog.1056 Taylor, 2003, Non-invasive fetal electrocardiography in singleton and multiple pregnancies, Br J Obstet Gynaecol, 110, 668, 10.1046/j.1471-0528.2003.02005.x Menendez, 2001, Usefulness of magnetocardiography for the investigation of fetal arrhythmias, Am J Cardiol, 88, 334, 10.1016/S0002-9149(01)01658-7 Hofbeck, 1997, Prenatal findings in patients with prolonged QT interval in the neonatal period, Heart, 77, 198, 10.1136/hrt.77.3.198 Groves, 1996, Outcome of isolated congenital complete heart block diagnosed in utero, Heart, 75, 190, 10.1136/hrt.75.2.190 Jaeggi, 2002, Outcome of children with fetal, neonatal or childhood diagnosis of isolated complete heart block. A single institution's experience of 30 years, J Am Coll Cardiol, 39, 130, 10.1016/S0735-1097(01)01697-7 Buyon, 1998, Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from the national lupus registry, J Am Coll Cardiol, 31, 1658, 10.1016/S0735-1097(98)00161-2 Schmidt, 1991, Perinatal outcome of fetal complete atrioventricular block: a multicenter experience, J Am Coll Cardiol, 17, 1360, 10.1016/S0735-1097(10)80148-2 Moak, 2001, Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela, J Am Coll Cardiol, 37, 238, 10.1016/S0735-1097(00)01048-2 Gladman, 2002, Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies, Am J Perinatol, 19, 73, 10.1055/s-2002-23555 Brucato, 2001, Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmuno-electrophoresis: a prospective study of 100 women, Arthritis Rheum, 44, 1832, 10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C Buyon, 1987, Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythemathosus. Experience in a mother with a predominance of SS-B (La) antibodies, Arthritis Rheum, 30, 44, 10.1002/art.1780300106 Bierman, 1988, Fetal hydrops and congenital complete heart block: response to maternal steroid therapy, J Pediatr, 112, 646, 10.1016/S0022-3476(88)80189-6 Kaaja, 1991, Congenital heart block: successful prophylactic treatment with intravenous gamma globulin and corticosteroid therapy, Am J Obstet Gynecol, 165, 1333, 10.1016/S0002-9378(12)90755-3 Carreira, 1993, Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus, J Rheumatol, 20, 1204 Carpenter, 1986, Fetal ventricular pacing for hydrops secondary to complete atrioventricular block, J Am Coll Cardiol, 8, 1434, 10.1016/S0735-1097(86)80319-9 Weindling, 1994, Staged pacing therapy for congenital complete heart block in premature infants, Am J Cardiol, 74, 412, 10.1016/0002-9149(94)90419-7 Martin, 1988, Successful management of congenital atrioventricular block associated with hydrops fetalis, J Pediatr, 112, 984, 10.1016/S0022-3476(88)80231-2 Anandakumar, 1996, Direct fetal therapy for hydrops secondary to congenital atrioventricular heart block, Obstet Gynecol, 87, 835 Barclay, 1987, Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies, Br J Obstet Gynecol, 94, 369, 10.1111/j.1471-0528.1987.tb03107.x van der Leij, 1994, Successful outcome of pregnancy after treatment of maternal anti-Ro (SS-A) antibodies with immunosuppressive therapy and plasmapheresis, Prenat Diagn, 14, 1003, 10.1002/pd.1970141019 Rosenthal, 2002, Validation of the Doppler PR interval in the fetus, J Am Soc Echocardiogr, 15, 1029, 10.1067/mje.2002.121438 Eronen, 2001, Congenital complete heart block in the fetus: hemodynamic features, antenatal treatment, and outcome in six cases, Pediatr Cardiol, 22, 385, 10.1007/s002460010256 Saleeb, 1999, Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody associated congenital heart block, Arthritis Rheum, 42, 2335, 10.1002/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3 Jaeggi, 2004, Transplacental treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease, Circulation, 110, 1542, 10.1161/01.CIR.0000142046.58632.3A Jaeggi, 1998, Atrial flutter in the fetal period: diagnosis, clinical features, treatment and outcome. A review, J Pediatr, 132, 335, 10.1016/S0022-3476(98)70455-X Van Engelen, 1994, Management, outcome and follow-up of fetal tachycardia, J Am Coll Cardiol, 24, 1371, 10.1016/0735-1097(94)90122-8 Simpson, 1998, Fetal tachycardias: management and outcome of 127 consecutive cases, Heart, 79, 576, 10.1136/hrt.79.6.576 Till, 1992, Atrial flutter in the fetus and young infant, Br Heart J, 67, 80, 10.1136/hrt.67.1.80 Oudijk, 2000, Sotalol in the treatment of fetal dysrhythmias, Circulation, 101, 2721, 10.1161/01.CIR.101.23.2721 Naheed, 1996, Fetal tachycardia: mechanisms and predictors of hydrops fetalis, J Am Coll Cardiol, 27, 1736, 10.1016/0735-1097(96)00054-X Triedman, 1996, Response of fetal tachycardia to transplacental procainamide, Cardiol Young, 6, 235, 10.1017/S1047951100003735 Allan, 1991, Flecainide in the treatment of fetal tachycardias, Br Heart J, 65, 46, 10.1136/hrt.65.1.46 Krapp, 2002, Flecainide in the intrauterine treatment of fetal supraventricular tachycardia, Ultrasound Obstet Gynecol, 19, 158, 10.1046/j.0960-7692.2001.00562.x Sonesson, 1998, Foetal supraventricular tachycardia treated with sotalol, Acta Paediatr, 87, 584, 10.1111/j.1651-2227.1998.tb01508.x Jouannic, 2003, Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy?, Prenat Diagn, 23, 152, 10.1002/pd.542 Strasburger, 2004, Amiodarone therapy for drug-refractory fetal tachycardia, Circulation, 109, 375, 10.1161/01.CIR.0000109494.05317.58 Hansmann, 1991, Fetal tachyarrhythmias: transplacental and direct treatment of the fetus – a report of sixty cases, Ultrasound Obstet Gynecol, 1, 162, 10.1046/j.1469-0705.1991.01030162.x Kohl, 1995, Direct fetal administration of adenosine for the termination of incessant supraventricular tachycardia, Obstet Gynecol, 85, 873, 10.1016/0029-7844(94)00314-4 Flack, 1993, Amiodarone given by three routes to terminate fetal atrial flutter associated with severe hydrops, Obstet Gynecol, 82, 483, 10.1097/00006250-199310000-00060 Lasser, 1993, Fetal response time to transplacental digoxin therapy for supraventricular tachyarrhythmia: a meta-analysis, J Mat Fetal Med, 2, 70, 10.3109/14767059309017229 Frohn-Mulder, 1995, The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia, Prenat Diagn, 15, 1297, 10.1002/pd.1970151309 Houyel, 1992, Electrophysiologic effects of sotalol on the immature mammalian heart, J Cardiovasc Pharmacol, 19, 134, 10.1097/00005344-199201000-00019 Jouannic, 2003, Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases, J Gynecol Obstet Biol Reprod, 32, 338